STANZA Trademark

Trademark Overview

On Wednesday, March 23, 2022, a trademark application was filed for STANZA with the United States Patent and Trademark Office. The USPTO has given the STANZA trademark a serial number of 97326559. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, July 8, 2025. This trademark is owned by Swing Therapeutics, Inc.. The STANZA trademark is filed in the Medical Instrument Products category with the following description:

Wearable electronic medical monitoring and reporting devices used to track and manage chronic health conditions, namely, fibromyalgia

General Information

Serial Number97326559
Word MarkSTANZA
Filing DateWednesday, March 23, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and ServicesWearable electronic medical monitoring and reporting devices used to track and manage chronic health conditions, namely, fibromyalgia

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSwing Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111
Party NameSwing Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94111

Trademark Events

Event DateEvent Description
Saturday, March 26, 2022NEW APPLICATION ENTERED
Tuesday, March 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 5, 2023ASSIGNED TO EXAMINER
Friday, January 13, 2023NON-FINAL ACTION WRITTEN
Friday, January 13, 2023NON-FINAL ACTION E-MAILED
Friday, January 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 1 FILED
Wednesday, January 3, 2024SOU EXTENSION 1 GRANTED
Friday, January 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2024SOU EXTENSION 2 FILED
Thursday, July 11, 2024SOU EXTENSION 2 GRANTED
Monday, January 13, 2025DIVISIONAL REQUEST RECEIVED
Monday, January 13, 2025TEAS REQUEST TO DIVIDE RECEIVED
Monday, January 13, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 8, 2025SOU EXTENSION 3 GRANTED
Tuesday, July 8, 2025DIVISIONAL PROCESSING COMPLETE
Wednesday, July 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 11, 2025CORRECTED NOA E-MAILED
Tuesday, July 8, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 13, 2025SOU EXTENSION 3 FILED

Related Keywords

stanza chronic manage health conditions fibromyalgia namely track used medical electronic